These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 16823854)

  • 1. Unexpected abundance of pathological tau in progressive supranuclear palsy white matter.
    Zhukareva V; Joyce S; Schuck T; Van Deerlin V; Hurtig H; Albin R; Gilman S; Chin S; Miller B; Trojanowski JQ; Lee VM
    Ann Neurol; 2006 Sep; 60(3):335-45. PubMed ID: 16823854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
    Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathology of variants of progressive supranuclear palsy.
    Dickson DW; Ahmed Z; Algom AA; Tsuboi Y; Josephs KA
    Curr Opin Neurol; 2010 Aug; 23(4):394-400. PubMed ID: 20610990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argyrophilic grain disease is a sporadic 4-repeat tauopathy.
    Togo T; Sahara N; Yen SH; Cookson N; Ishizawa T; Hutton M; de Silva R; Lees A; Dickson DW
    J Neuropathol Exp Neurol; 2002 Jun; 61(6):547-56. PubMed ID: 12071638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Nonaka T; Hasegawa M; Ishiguro K; Iritani S; Tsuchiya K; Iseki E; Yagishita S; Oda T; Mochizuki A
    Ann Neurol; 2004 Jan; 55(1):72-9. PubMed ID: 14705114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau-positive fine granules in the cerebral white matter: a novel finding among the tauopathies exclusive to parkinsonism-dementia complex of Guam.
    Yamazaki M; Hasegawa M; Mori O; Murayama S; Tsuchiya K; Ikeda K; Chen KM; Katayama Y; Oyanagi K
    J Neuropathol Exp Neurol; 2005 Oct; 64(10):839-46. PubMed ID: 16215455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.
    Yoshida M
    Neuropathology; 2006 Oct; 26(5):457-70. PubMed ID: 17080726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy.
    Liu WK; Le TV; Adamson J; Baker M; Cookson N; Hardy J; Hutton M; Yen SH; Dickson DW
    Ann Neurol; 2001 Oct; 50(4):494-502. PubMed ID: 11601500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype.
    Koga S; Kouri N; Walton RL; Ebbert MTW; Josephs KA; Litvan I; Graff-Radford N; Ahlskog JE; Uitti RJ; van Gerpen JA; Boeve BF; Parks A; Ross OA; Dickson DW
    Acta Neuropathol; 2018 Sep; 136(3):389-404. PubMed ID: 29926172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical progressive supranuclear palsy with corticospinal tract degeneration.
    Josephs KA; Katsuse O; Beccano-Kelly DA; Lin WL; Uitti RJ; Fujino Y; Boeve BF; Hutton ML; Baker MC; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):396-405. PubMed ID: 16691120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
    Martínez-Maldonado A; Ontiveros-Torres MÁ; Harrington CR; Montiel-Sosa JF; Prandiz RG; Bocanegra-López P; Sorsby-Vargas AM; Bravo-Muñoz M; Florán-Garduño B; Villanueva-Fierro I; Perry G; Garcés-Ramírez L; de la Cruz F; Martínez-Robles S; Pacheco-Herrero M; Luna-Muñoz J
    J Alzheimers Dis; 2021; 79(4):1517-1531. PubMed ID: 33459640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signature tau neuropathology in gray and white matter of corticobasal degeneration.
    Forman MS; Zhukareva V; Bergeron C; Chin SS; Grossman M; Clark C; Lee VM; Trojanowski JQ
    Am J Pathol; 2002 Jun; 160(6):2045-53. PubMed ID: 12057909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter.
    Zhukareva V; Mann D; Pickering-Brown S; Uryu K; Shuck T; Shah K; Grossman M; Miller BL; Hulette CM; Feinstein SC; Trojanowski JQ; Lee VM
    Ann Neurol; 2002 Jun; 51(6):730-9. PubMed ID: 12112079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies.
    Roemer SN; Brendel M; Gnörich J; Malpetti M; Zaganjori M; Quattrone A; Gross M; Steward A; Dewenter A; Wagner F; Dehsarvi A; Ferschmann C; Wall S; Palleis C; Rauchmann BS; Katzdobler S; Jäck A; Stockbauer A; Fietzek UM; Bernhardt AM; Weidinger E; Zwergal A; Stöcklein S; Perneczky R; Barthel H; Sabri O; Levin J; Höglinger GU; Franzmeier N
    Brain; 2024 Jul; 147(7):2428-2439. PubMed ID: 38842726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
    Briel N; Pratsch K; Roeber S; Arzberger T; Herms J
    Brain Pathol; 2021 Jul; 31(4):e12914. PubMed ID: 33089580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
    Sakae N; Josephs KA; Litvan I; Murray ME; Duara R; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
    Mov Disord; 2019 Nov; 34(11):1655-1662. PubMed ID: 31433871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
    Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
    Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau protein profiling in tauopathies: a human brain study.
    Lantero-Rodriguez J; Camporesi E; Montoliu-Gaya L; Gobom J; Piotrowska D; Olsson M; Burmann IM; Becker B; Brinkmalm A; Burmann BM; Perkinton M; Ashton NJ; Fox NC; Lashley T; Zetterberg H; Blennow K; Brinkmalm G
    Mol Neurodegener; 2024 Jul; 19(1):54. PubMed ID: 39026372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.